Enterprise Value
7.685B
Cash
1.487B
Avg Qtr Burn
-102.1M
Short % of Float
11.96%
Insider Ownership
0.61%
Institutional Own.
-
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
VAX-24 Details Invasive pneumococcal disease, Infectious disease | Phase 3 Data readout | |
VAX-24 Details Infectious disease, Invasive pneumococcal disease | Phase 2 Data readout | |
VAX-31 Details Invasive pneumococcal disease, Infectious disease, Vaccine | Phase 1/2 Data readout |